<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0047103</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2974</journal-id>
<journal-id journal-id-type="nlm-ta">Circ Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Circ. Res.</journal-id>
<journal-title-group>
<journal-title>Circulation research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0009-7330</issn>
<issn pub-type="epub">1524-4571</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27765793</article-id>
<article-id pub-id-type="pmc">5516949</article-id>
<article-id pub-id-type="doi">10.1161/CIRCRESAHA.116.309283</article-id>
<article-id pub-id-type="manuscript">NIHMS824857</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Precision Medicine Approach to the Rescue of Function on Malignant Calmodulinopathic Long QT Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Limpitikul</surname>
<given-names>Worawan B.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dick</surname>
<given-names>Ivy E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tester</surname>
<given-names>David J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boczek</surname>
<given-names>Nicole J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Limphong</surname>
<given-names>Pattraranee</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Wanjun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>Myoung Hyun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Babich</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>DiSilvestre</surname>
<given-names>Deborah</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kanter</surname>
<given-names>Ronald J.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tomaselli</surname>
<given-names>Gordon F.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ackerman</surname>
<given-names>Michael J.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yue</surname>
<given-names>David T.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Calcium Signals Laboratory, Department of Biomedical Engineering, The Johns Hopkins University School of Medicine, Ross Research Building, Room 713, 720 Rutland Avenue, Baltimore, MD 21205</aff>
<aff id="A2"><label>2</label>Department of Physiology, The University of Maryland School of Medicine, 660 West Redwood St, Howard Hall, Room 511, Baltimore, MD 21205</aff>
<aff id="A3"><label>3</label>Departments of Cardiovascular Diseases (Division of Heart Rhythm Services), Pediatrics (Division of Pediatric Cardiology), and Molecular Pharmacology and Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Guggenheim 501, Mayo Clinic, Rochester, MN, 55905</aff>
<aff id="A4"><label>4</label>Division of Cardiology, Department of Medicine, The Johns Hopkins University School of Medicine, Ross Research Building, Room 844, 720 Rutland Avenue Baltimore, MD 21205</aff>
<aff id="A5"><label>5</label>Division of Cardiology, Nicklaus Childrenâ€™s Hospital, Miami, FL, 33155</aff>
<author-notes>
<corresp id="cor1"><bold>Address correspondence to:</bold> Dr. Gordon Tomaselli, Department of Medicine, The Johns Hopkins Univ. School of Medicine, Ross Research Building, Room 844, 720 Rutland Avenue, Baltimore, MD 21205, Tel: 410-955-2774, Fax: 410-502-2096, <email>gtomasel@jhmi.edu</email>, Dr. Michael Ackerman, Departments of Cardiovascular Diseases, Mayo Clinic, Guggenheim 501, Rochester, MN, 55905, Tel: 507-284-0101, Fax: 507-284-3757, <email>ackerman.michael@mayo.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>27</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>06</day>
<month>1</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>120</volume>
<issue>1</issue>
<fpage>39</fpage>
<lpage>48</lpage>
<!--elocation-id from pubmed: 10.1161/CIRCRESAHA.116.309283-->
<abstract>
<sec id="S1">
<title>Rationale</title>
<p id="P1">Calmodulinopathies comprise a new category of potentially life-threatening genetic arrhythmia syndromes capable of producing severe long QT syndrome (LQTS) with mutations involving either <italic>CALM1, CALM2</italic>, or <italic>CALM3</italic>. The underlying basis of this form of LQTS is a disruption of Ca<sup>2+</sup>/CaM-dependent inactivation (CDI) of L-type Ca<sup>2+</sup> channels (LTCCs).</p>
</sec>
<sec id="S2">
<title>Objective</title>
<p id="P2">To gain insight into the mechanistic underpinnings of calmodulinopathies and devise new therapeutic strategies for the treatment of this form of LQTS.</p>
</sec>
<sec id="S3">
<title>Methods and Results</title>
<p id="P3">We generated and characterized the functional properties of iPSC-derived cardiomyocytes (iPSC-CMs) from a patient with D130G-<italic>CALM2</italic>-mediated LQTS, thus creating a platform with which to devise and test novel therapeutic strategies. The patient-derived iPSC-CMs display (1) significantly prolonged action potentials (APs), (2) disrupted Ca<sup>2+</sup> cycling properties, and (3) diminished CDI of LTCCs. Next, taking advantage of the fact that calmodulinopathy patients harbor a mutation in only one of six redundant CaM-encoding alleles, we devised a strategy using CRISPR interference (CRISPRi) to selectively suppress the mutant gene while sparing the wild-type counterparts. Indeed, suppression of <italic>CALM2</italic> expression produced a functional rescue in iPSC-CMs with D130G-<italic>CALM2</italic>, as shown by the normalization of AP duration and CDI following treatment. Moreover, CRISPRi can be designed to achieve selective knockdown of any of the three <italic>CALM</italic> genes, making it a generalizable therapeutic strategy for any calmodulinopathy.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">Overall, this therapeutic strategy holds great promise for calmodulinopathy patients as it represents a generalizable intervention capable of specifically altering CaM expression and potentially attenuating LQTS-triggered cardiac events, thus initiating a path towards precision medicine.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Long-QT syndrome</kwd>
<kwd>Calmodulin</kwd>
<kwd>L-type calcium channels</kwd>
<kwd>Ca<sup>2+</sup>-CaM-dependent inactivation (CDI)</kwd>
<kwd>induced-pluripotent stem cells (iPSCs)</kwd>
</kwd-group>
<kwd-group>
<title>Subject Terms</title>
<kwd>Ion Channels/Membrane Transport</kwd>
<kwd>Electrophysiology</kwd>
<kwd>Stem Cells</kwd>
<kwd>Gene Therapy</kwd>
<kwd>Arrhythmias</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>